Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 5
2019 7
2020 5
2021 3
2022 7
2023 6
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
MondoA and AKI and AKI-to-CKD Transition.
Maeda S, Sakai S, Takabatake Y, Yamamoto T, Minami S, Nakamura J, Namba-Hamano T, Takahashi A, Matsuda J, Yonishi H, Matsui S, Imai A, Edahiro R, Yamamoto-Imoto H, Matsui I, Takashima S, Imamura R, Nonomura N, Yanagita M, Okada Y, Ballabio A, Nakamura S, Yoshimori T, Isaka Y. Maeda S, et al. J Am Soc Nephrol. 2024 May 31;35(9):1164-82. doi: 10.1681/ASN.0000000000000414. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38819935
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Foghsgaard S, Vedtofte L, Andersen ES, Bahne E, Andreasen C, Sørensen AL, Forman JL, Mathiesen ER, Svare JA, Clausen TD, Damm P, Holst JJ, Knop FK, Vilsbøll T. Foghsgaard S, et al. Diabetes Obes Metab. 2024 Jan;26(1):201-214. doi: 10.1111/dom.15306. Epub 2023 Oct 17. Diabetes Obes Metab. 2024. PMID: 37846555 Clinical Trial.
GR-KLF15 pathway controls hepatic lipogenesis during fasting.
Takeuchi Y, Murayama Y, Aita Y, Mehrazad Saber Z, Karkoutly S, Tao D, Katabami K, Ye C, Shikama A, Masuda Y, Izumida Y, Miyamoto T, Matsuzaka T, Kawakami Y, Shimano H, Yahagi N. Takeuchi Y, et al. FEBS J. 2024 Jan;291(2):259-271. doi: 10.1111/febs.16957. Epub 2023 Sep 21. FEBS J. 2024. PMID: 37702262
Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial.
Kühne T, Wallace E, Herzig D, Helleputte S, Scott S, Pickles J, Melmer A, Stettler C. Kühne T, et al. Diabetes Obes Metab. 2024 Jul;26(7):2645-2651. doi: 10.1111/dom.15580. Epub 2024 Apr 1. Diabetes Obes Metab. 2024. PMID: 38558517 Free article. Clinical Trial.
Incorporating dialogue in laboratory teaching.
Seery MK, Agustian HY, Christiansen FV, Gammelgaard B, Malm RH. Seery MK, et al. Anal Bioanal Chem. 2024 Nov;416(28):6165-6170. doi: 10.1007/s00216-024-05569-2. Epub 2024 Oct 1. Anal Bioanal Chem. 2024. PMID: 39352472 Free PMC article. No abstract available.
42 results